CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Geneart AG is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Geneart AG
5791 Van Allen Way
Phone: 1.760.603.7200p:1.760.603.7200 Carlsbad, CA  92008  United States Ticker: G6AG6A
This company is no longer actively traded on any major stock exchange.
This is a Subsidiary, click here for the Parent Company
Business Summary
Geneart AG is a Germany-based company engaged in the provision of integrated system solutions for deoxyribonucleic acid (DNA) engineering and processing in order to deliver improved drugs and biotech products. It is divided into three business areas: Red Biotechnology, active in the filed of protein drugs, deoxyribonucleic acid (DNA)-based drugs and recombinant vaccines; White Biotechnology, includes biocatalysts, and Green Biotechnology, engaged in production of biopharmaceuticals in plants and transgenic plants. Geneart's core business is gene synthesis and the production of artificial genes. Its spectrum of services includes gene optimization and synthesis, gene evolution services, and the development and manufacture of deoxyribonucleic acid (DNA)-based agents, including plasmid DNA. In May 2010, Life Technologies Corporation acquired 59% interest in Geneart AG.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/201012/31/2009Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
2836 Biological products, except diagnostic substances
2833 Medicinal chemicals and botanical products

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chief Executive Officer, Chief Scientific Officer RalfWagner 2/21/2006
Member of the Management Board, Chief Financial Officer DanielSeibert 40 6/2/2009 6/2/2009
Member of the Management Board, Chief Operating Officer MarcusGraf 5/1/2009 5/1/2009
Member of the Management Board, Chief Business Officer BerndMerkl 5/1/2009 5/1/2009

Business Names
Business Name
G6A
Geneart AG

General Information
Number of Employees: 185 (As of 9/30/2010)
Outstanding Shares: 4,487,800 (As of 9/30/2010)
Stock Exchange: ETR


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023